Drug intelligence / Profile preview

Baijianggu

Development stage
Unknown
Lead developer
Baiyiyuan BioTech
Modality
Hydrogel Systems → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration
Surgical Application
01

Overview

Baijianggu is an absorbable biological membrane developed by Baiyiyuan BioTech, composed of Small Intestinal Submucosa-derived Extracellular Matrix (SIS-ECM). It functions as a bioactive scaffold that facilitates endogenous tissue regeneration and wound healing by providing a structural framework for cellular attachment, migration, and tissue remodeling. The membrane is intended for surgical use in wound repair and tissue reconstruction, where it serves as a temporary barrier or reinforcement that is eventually absorbed and replaced by the patient's own native tissue. As a biomaterial-based medical device, it leverages the regenerative properties of the extracellular matrix to promote healing without the need for traditional pharmaceutical active ingredients.

Brand names
Baijianggu百建固
Other names
Absorbable biological membrane可吸收生物膜SIS-ECM membrane

Beyond the preview

Go deeper on Baijianggu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baijianggu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call